Evidence map›Paper›PMID 35072577›Full record

ArticleTechnology in cancer research & treatment

Prognostic Significance of Platelet (PLT) and Platelet to Mean Platelet Volume (PLT/MPV) Ratio During Apatinib Second-Line or Late-Line Treatment in Advanced Esophageal Squamous Cell Carcinoma Patients.

Rixin Su, Jingya Zhu, Shusheng Wu, Huiqin Luo, Yifu He

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Technology in cancer research & treatment. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Rixin SuAnhui Provincial Hospital Affiliated to Anhui Medical University, Luyang District, Hefei, China.ORCID 0000-0002-4522-1689
Jingya ZhuAnhui Provincial Hospital Affiliated to Anhui Medical University, Luyang District, Hefei, China.
Shusheng WuWest Branch of the First Affiliated Hospital of University of Science and Technology of China, Shushan District, Hefei, China Rixin Su and Jingya Zhu contributed equally to this work and should be considered co-first authors.
Huiqin LuoWest Branch of the First Affiliated Hospital of University of Science and Technology of China, Shushan District, Hefei, China Rixin Su and Jingya Zhu contributed equally to this work and should be considered co-first authors.ORCID 0000-0001-7550-3719
Yifu HeWest Branch of the First Affiliated Hospital of University of Science and Technology of China, Shushan District, Hefei, China Rixin Su and Jingya Zhu contributed equally to this work and should be considered co-first authors.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Mean Platelet VolumePlatelet CountAdultAgedCombined Modality TherapyEsophageal Squamous Cell CarcinomaFemaleHumansKaplan-Meier EstimateMaleMiddle AgedNeoplasm MetastasisNeoplasm StagingPrognosisProtein Kinase InhibitorsPyridinesapatinibProtein Kinase InhibitorsPyridinesAdvanced esophageal squamous cell carcinomaESCCplateletplatelet to mean platelet volume ratioPLTPLT/MPV

Identifiers

PMID35072577
PMCPMC8808027

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.